EMILY VOLK: Open Payments
NPI 1407176035 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 60 payments from 16 companies in 2025. Trend: 2023 $666 · 2024 $1,093 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $323 |
| ABBVIE INC. | 11 | $200 |
| Corcept Therapeutics | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| PFIZER INC. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
Products named: Wegovy, Korlym, UBRELVY, CAPLYTA, AIRSUPRA, VRAYLAR, REXULTI, Auvelity.
Industry payments across NC — which companies pay providers there.
